Renal and nonrenal 25-hydroxyvitamin D-1α-hydroxylases and their clinical significance

Journal of Bone and Mineral Research

Volumn 13, Issue 3, 1998, Pages 350-353

  Bell, Norman H ^a  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM ION; OXYGENASE;

CALCIUM HOMEOSTASIS; ENZYME REGULATION; HUMAN; REVIEW; TISSUE SPECIFICITY; VITAMIN D METABOLISM;

CALCITRIOL; CALCIUM; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERFERON TYPE II; KIDNEY TUBULES, PROXIMAL; MACROPHAGES; PARATHYROID HORMONE; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 0031944517     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.3.350     Document Type: Review

References (42)

1. Garabedian M, Holick MF, DeLuca HF, Boyle IT 1972 Control of 25-hydroxycholecalciferol metabolism by the parathyroid glands. Proc Natl Acad Sci USA 69:1673-1676.
2. Fraser DR, Kodicek E 1973 Regulation of 25-hydroxycholecal-ciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nat New Biol 241:163-166.
3. 3 by calcium and phosphate in the rat. Science 190:578-580.
4. 3. Endocrinology 127:453-459.
5. Nesbitt T, Drezner MK 1993 Insulin-like growth factor-I regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity. Endocrinology 132:133-138.
6. Ohmdahl JL, Gray RW, Boyle IT, Knutson J, DeLuca HF 1972 Regulation of metabolism of 25-hydroxycholeclaciferol by kidney tissue in vitro by dietary calcium. Nat New Biol 237:63-64.
7. 3 independently of PTH and phosphorus in the rat. J Clin Invest 76:1599-1604.
8. Hutter HN, Halloran BP, Toto RD, Peterson JG 1985 Long-term control of plasma calcitriol concentration in experimental hyperparathyroidism: Dominant role of plasma calcium concentration in experimental hyperparathyroidism. J Clin Invest 76:695-702.
9. Tanaka Y, DeLuca HF 1973 The control of 25-hydroxyvitamin D metabolism by phosphorus. Arch Biochem Biophys 154: 566-574.
10. Portale AA, Halloran BP, Murphy MM, Morris RC Jr 1986 Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans. J Clin Invest 77:7-12.
11. 3 1α-hydroxylase and vitamin D synthesis. Science 277:1827-1830.
12. St.-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH 1997 The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDRR) disease locus. J Bone Miner Res 12:1552-1559.
13. 3 through C-24 oxidation pathway. Biochemistry 28:11763-11769.
14. 3 to calcitroic acid: Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 262:173-180.
15. Armbrecht H, Boltz MMA 1991 Expression of 25-hydroxyvitamin D-24-hydroxylase cytochrome P450 in kidney and intestine: Effect of 1,25-dihydroxyvitamin D and age. FEBS Lett 292:17-20.
16. St.-Arnaud R, Arabian A, Travers R, Glorieux FH 1997 Abnormal intramembranous ossification in mice deficient for the vitamin D 24-hydroxylase gene. In: Norman AW, Bouillon R, Thomasset M (eds.) Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. University of California, Printing and Reprographics, Riverside, CA, U.S.A., p. 65.
17. 3 administration in the rat reduces the serum concentration of 25-hydroxyvitamin D by increasing metabolic clearance rate. J Clin Invest 78:622-628.
18. Bell NH, Shaw S, Turner RT 1984 Evidence that 1,25-dihydroxyvitamin D inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest 74:1540-1544.
19. Fraser D, Kooh SW, Kind HO, Holick MF, Tanaka Y, DeLuca HF 1973 Pathogenesis of hereditary vitamin D dependent rickets: An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. N Engl J Med 289:817-822.
20. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF 1979 Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: Effects of age and dietary calcium. J Clin Invest 64:729-736.
21. 3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults. J Clin Endocrinol Metab 48:1008-1016.
22. Garrett JE, Capuano IV, Hammerland LG, Humg BCP, Brown EM, Hebert SC, Nemeth ER, Fuller F 1995 Molecular cloning and functional expression of human parathyroid hormone calcium receptor cDNAs. J Biol Chem 270:12919-12925.
23. Brown EM, Hebert SC 1997 Calcium-receptor-regulated parathyroid and renal function. Bone 20:303-309.
24. Stern PH, Taylor AB, Bell NH, Epstein S 1981 Demonstration that circulating 1α,25-dihydroxyvitamin D is loosely regulated in normal children. J Clin Invest 68:1374-1377.
25. Bell NH, Stern PH, Paulson SK 1985 Circulating 1α,25-dihydroxyvitamin D is tightly regulated in black children (letter). N Engl J Med 313:1418.
26. Basile JN, Liel Y, Shary J, Bell NH 1993 Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis. J Clin Invest 91:2396-1398.
27. Juttmann JR, Visser TJ, Buurman C, de Kam E, Birkenhager JC 1981 Seasonal fluctuations in serum concentrations of vitamin D metabolites in normal subjects. Br Med J 282:1349-1352.
28. Katz BS, Jackson GJ, Hollis BW, Bell NH 1993 Diagnostic criteria of vitamin D deficiency. The Endocrinologist 3:248-253.
29. Lambert PW, Stern PH, Avioli RC, Brackett NC, Turner RT, Greene A, Fu I, Bell NH 1982 Evidence for extrarenal production of 1α,25-dihydroxyvitamin D in man. J Clin Invest 69:722-725.
30. Dusso AS, Lopez-Hilker S, Rapp N, Slatopolsky E 1988 Extrarenal production of calcitriol in chronic renal failure. Kidney Int 34:368-375.
31. Dusso AS, Finch J, Brown A, Ritter C, Delmez J, Schreiner G, Slatopolsky E 1991 Extrarenal production of calcitriol in normal and uremie humans. J Clin Endocrinol Metab 72:157-164.
32. Bell NH, Stern PH, Pantzer E, Sinha TK, DeLuca HF 1979 Evidence that increased circulating 1α,25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest 64:218-225.
33. Papapoulos SE, Clemens TL, Fraher LJ, Lewin IG, Sandler LM, O'Riordan JLH 1979 1,25-Dihydroxycholecalciferol in the pathogenesis of the hypercalcemia of sarcoid. Lancet 1:627-630.
34. Bell NH 1998 Sarcoidosis and related disorders. In: Avioli LV, Krane SM (eds.) Metabolic Bone Disease and Clinically Related Disorders, 3rd Ed. Academic Press, San Diego, CA, U.S.A., pp. 607-619.
35. Adams JS 1997 Extrarenal production of active vitamin D metabolites in human lymphoproliferative diseases. In: Feldman D, Glorieux FH, Pike JW (eds.) Vitamin D. Academic Press, San Diego, CA, U.S.A., pp. 903-921.
36. 3. N Engl J Med 305:440-443.
37. Gkonos PJ, London R, Hendler ED 1984 Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end stage renal disease and active tuberculosis. N Engl J Med 305:368-375.
38. Robinson BWS, McLemore TL, Crystal RG 1985 Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 72:1488-1495.
39. Adams JS, Gacad MA 1985 Characterization of 1α-hydroxylation of vitamin D, sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 161:755-765.
40. 3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J Clin Endocrinol Metab 65:1201-1209.
41. Adams JS, Modlin RL, Diz MM, Barnes PF 1989 Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. J Clin Endocrinol Metab 69:457-460.
42. 3 in human monocytes and macrophages: A mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 82:2222-2232.